The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Treatment noncompliance 1
RITUXIMAB Tumour haemorrhage 1
Rituximab Type 2 diabetes mellitus 1
RITUXIMAB Ulcer 1
Rituximab Umbilical hernia, obstructive 1
RITUXIMAB Unevaluable event 1
Rituximab Upper respiratory tract inflammation 1
Rituximab Urethral caruncle 1
Rituximab Vaccination failure 1
rituximab Vena cava thrombosis 1
Rituximab Ventricular fibrillation 1
RITUXIMAB Ventricular tachycardia 1
Rituximab Vertigo 1
Rituximab Viral myocarditis 1
RITUXIMAB Visceral leishmaniasis 1
RITUXIMAB Visual impairment 1
RITUXIMAB Vitamin B12 deficiency 1
RITUXIMAB Vocal cord atrophy 1
Rituximab Weight fluctuation 1
RITUXIMAB Weight increased 1

Total Records: 1,104     Number of Pages: 56